Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

9.1.1 Anaemias

Roxadustat (Evrenzo) This High-Cost Drug has been approved for the following indications: -Treating symptomatic anaemia in chronic kidney disease. For specialist initiation and ongoing prescribing by renal prescribers only
For more information and NICE Guidance Click Here
Roxadustat for treating symptomatic anaemia in chronic kidney disease NICE Guidance TA807
  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •